IXC 2.78% 7.0¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-7

  1. 1,050 Posts.
    lightbulb Created with Sketch. 269
    Best path forward. People forget how big Europe is and always focus on the US and dealing with the FDA who seem to have become very arrogant.
    We can deal with them later

    I think this is the best path forward. We are a phase 3 company!
    well done to management..
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
-0.002(2.78%)
Mkt cap ! $5.561M
Open High Low Value Volume
7.4¢ 7.6¢ 7.0¢ $7.077K 100.0K

Buyers (Bids)

No. Vol. Price($)
1 50000 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5000 1
View Market Depth
Last trade - 10.58am 30/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.